Mesothelioma Blood Test May Be Possible
|

Mesothelioma Blood Test May Be Possible

An international team of researchers is studying the proteins found on the surface of cancer cells in an effort to improve mesothelioma diagnosis. The team, made up of scientists from the US, Switzerland, Italy and Chile, has just published their findings on a new kind of test to identify protein-derived mesothelioma biomarkers in blood serum. Mesothelioma is an aggressive cancer of the membranes around organs. Because the most common mesothelioma biomarker, mesothelin, is also overproduced by other kinds of cancer cells, it has only limited diagnostic value. A test to identify a set of proteins produced specifically by mesothelioma cells could greatly improve diagnostic accuracy. Led by Ferdinando Cerciello and Bernd Wollscheid of the Institute of Molecular Systems Biology in…

New Detection System for Mesothelioma
| |

New Detection System for Mesothelioma

A team of biotech scientists in New York have developed an electrochemical process they say can help clinicians detect mesothelioma cells in blood serum. The system works by detecting a protein (HAPLN1) known to be expressed at high levels in the blood serum of people with malignant pleural mesothelioma. Detecting mesothelioma as early as possible is of critical importance because mesothelioma is such a difficult cancer to treat. Associated with asbestos exposure, mesothelioma starts on the membrane around the lungs, heart, or abdomen. It typically grows quickly and does not respond to conventional treatments like chemotherapy or radiotherapy. Biomarkers like the HAPLN1 protein may be value if they can help clinicians distinguish mesothelioma from other conditions with similar symptoms. The scientists…